Rite Aid Pharmacy #10454 Durable Medical Equipment & Medical Supplies Location: 121 W Main St, Moorestown, New Jersey 08057 Phone: (856) 866-1533 |
Cvs Pharmacy #02409 Durable Medical Equipment & Medical Supplies Location: 219 W Main St, Moorestown, New Jersey 08057 Phone: (856) 914-2021 |
Carl's Shoes Inc Durable Medical Equipment & Medical Supplies Location: 27 W Main St, Moorestown, New Jersey 08057 Phone: (856) 235-6223 |
Le Grand Associates Inc DME Supplier - Customized Equipment Location: 214 W Main St, Moorestown, New Jersey 08057 Phone: (856) 273-8565 |
South Jersey Eye Physicians Durable Medical Equipment & Medical Supplies Location: 509 S Lenola Rd, Moorestown, New Jersey 08057 Phone: (856) 234-0258 |
Lenscrafters #01045 Eyewear Supplier (Equipment, not the service) Location: 400 W Route 38, Moorestown, New Jersey 08057 Phone: (856) 787-0102 |
News Archive
In celebration of Kavli Prize Week, the Norwegian University of Science and Technology (NTNU), the Norwegian Academy of Science and Letters, and the Kavli Foundation will hold a series of lectures and events on 9 September 2010 in Trondheim, Norway at the NTNU campus. The event features a number of 2010 Kavli Prize Laureates. The festivities continue after the official celebration, with two symposia sponsored by NTNU, one in neuroscience and one in nanoscience.
New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Health care spending per privately insured American increased 7.4 percent in 2003—the first major slowdown in spending growth in nearly a decade.
MIT researchers have developed a new technique for imaging brain tissue at multiple scales, allowing them to peer at molecules within cells or take a wider view of the long-range connections between neurons.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.
› Verified 8 days ago